12:00 AM
 | 
Aug 13, 2012
 |  BC Week In Review  |  Company News  |  Other News

Shang Pharma supply/service news

ShangPharma retained JP Morgan as a financial advisor. The firm will assist the independent committee formed to review a non-binding acquisition proposal letter from the Chinese CRO's CEO and Chairman...

Read the full 129 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >